HEADER TRANSFERASE/INHIBITOR 05-JAN-21 7L9Y TITLE HUMAN PARP14 (ARTD8), CATALYTIC FRAGMENT IN COMPLEX WITH RBN012042 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN MONO-ADP-RIBOSYLTRANSFERASE PARP14; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 8,ARTD8,B COMPND 5 AGGRESSIVE LYMPHOMA PROTEIN 2,POLY [ADP-RIBOSE] POLYMERASE 14,PARP- COMPND 6 14; COMPND 7 EC: 2.4.2.-; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PARP14, BAL2, KIAA1268; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PARP14, ARTD8, MONOPARP, ADP RIBOSYLATION, INHIBITOR COMPLEX, KEYWDS 2 TRANSFERASE-INHIBITOR COMPLEX, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR B.W.DORSEY,K.K.SWINGER,L.B.SCHENKEL,W.D.CHURCH,N.R.PERL, AUTHOR 2 M.M.VASBINDER,T.J.WIGLE,K.W.KUNTZ REVDAT 3 18-OCT-23 7L9Y 1 REMARK REVDAT 2 23-JUN-21 7L9Y 1 JRNL REVDAT 1 21-APR-21 7L9Y 0 JRNL AUTH T.J.WIGLE,Y.REN,J.R.MOLINA,D.J.BLACKWELL,L.B.SCHENKEL, JRNL AUTH 2 K.K.SWINGER,K.KUPLAST-BARR,C.R.MAJER,W.D.CHURCH,A.Z.LU,J.MO, JRNL AUTH 3 R.ABO,A.CHEUNG,B.W.DORSEY,M.NIEPEL,N.R.PERL,M.M.VASBINDER, JRNL AUTH 4 H.KEILHACK,K.W.KUNTZ JRNL TITL TARGETED DEGRADATION OF PARP14 USING A HETEROBIFUNCTIONAL JRNL TITL 2 SMALL MOLECULE. JRNL REF CHEMBIOCHEM V. 22 2107 2021 JRNL REFN ESSN 1439-7633 JRNL PMID 33838082 JRNL DOI 10.1002/CBIC.202100047 REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.16 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 44437 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.268 REMARK 3 R VALUE (WORKING SET) : 0.266 REMARK 3 FREE R VALUE : 0.298 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2273 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.25 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.31 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3210 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.65 REMARK 3 BIN R VALUE (WORKING SET) : 0.4510 REMARK 3 BIN FREE R VALUE SET COUNT : 174 REMARK 3 BIN FREE R VALUE : 0.4700 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6057 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 125 REMARK 3 SOLVENT ATOMS : 77 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.29 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.76000 REMARK 3 B22 (A**2) : 11.34000 REMARK 3 B33 (A**2) : -7.58000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.348 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.257 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.399 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 19.703 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.935 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.915 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6403 ; 0.007 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 5697 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8717 ; 1.474 ; 1.683 REMARK 3 BOND ANGLES OTHERS (DEGREES): 13117 ; 1.160 ; 1.610 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 759 ; 7.419 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 369 ;34.019 ;22.954 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 961 ;15.294 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 32 ;22.901 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 800 ; 0.058 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 7462 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1614 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NCS TYPE: LOCAL REMARK 3 NUMBER OF DIFFERENT NCS PAIRS : 6 REMARK 3 GROUP CHAIN1 RANGE CHAIN2 RANGE COUNT RMS WEIGHT REMARK 3 1 A 1615 1801 B 1615 1801 6214 0.070 0.050 REMARK 3 2 A 1615 1801 C 1615 1801 6019 0.090 0.050 REMARK 3 3 A 1615 1800 D 1615 1800 5972 0.090 0.050 REMARK 3 4 B 1615 1801 C 1615 1801 6050 0.090 0.050 REMARK 3 5 B 1615 1800 D 1615 1800 6008 0.090 0.050 REMARK 3 6 C 1615 1800 D 1615 1800 6220 0.060 0.050 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES: REFINED INDIVIDUALLY REMARK 4 REMARK 4 7L9Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-JAN-21. REMARK 100 THE DEPOSITION ID IS D_1000253575. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-FEB-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0332 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44437 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 46.160 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.15200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.31 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 6.60 REMARK 200 R MERGE FOR SHELL (I) : 1.09500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3SMJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.73 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES PH 7.0, 26% V/V JEFFAMINE REMARK 280 ED-2001, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.32500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 72.27000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 46.11500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 72.27000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.32500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 46.11500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1608 REMARK 465 ASN A 1609 REMARK 465 ALA A 1610 REMARK 465 ASP A 1611 REMARK 465 MET A 1612 REMARK 465 LYS A 1613 REMARK 465 GLN A 1614 REMARK 465 SER B 1608 REMARK 465 ASN B 1609 REMARK 465 ALA B 1610 REMARK 465 ASP B 1611 REMARK 465 MET B 1612 REMARK 465 LYS B 1613 REMARK 465 GLN B 1614 REMARK 465 SER C 1608 REMARK 465 ASN C 1609 REMARK 465 ALA C 1610 REMARK 465 ASP C 1611 REMARK 465 MET C 1612 REMARK 465 LYS C 1613 REMARK 465 GLN C 1614 REMARK 465 SER D 1608 REMARK 465 ASN D 1609 REMARK 465 ALA D 1610 REMARK 465 ASP D 1611 REMARK 465 MET D 1612 REMARK 465 LYS D 1613 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A1624 -19.55 -47.90 REMARK 500 TYR A1727 -66.69 -101.24 REMARK 500 ASN A1776 116.89 -163.69 REMARK 500 PRO B1624 -14.49 -47.92 REMARK 500 TYR B1727 -66.69 -101.43 REMARK 500 ASN B1776 117.61 -163.11 REMARK 500 SER C1625 -0.85 82.51 REMARK 500 TYR C1727 -68.05 -101.34 REMARK 500 ASN C1776 117.78 -162.89 REMARK 500 TYR D1727 -67.67 -101.11 REMARK 500 ASN D1776 117.80 -163.05 REMARK 500 REMARK 500 REMARK: NULL DBREF 7L9Y A 1611 1801 UNP Q460N5 PAR14_HUMAN 1530 1720 DBREF 7L9Y B 1611 1801 UNP Q460N5 PAR14_HUMAN 1530 1720 DBREF 7L9Y C 1611 1801 UNP Q460N5 PAR14_HUMAN 1530 1720 DBREF 7L9Y D 1611 1801 UNP Q460N5 PAR14_HUMAN 1530 1720 SEQADV 7L9Y SER A 1608 UNP Q460N5 EXPRESSION TAG SEQADV 7L9Y ASN A 1609 UNP Q460N5 EXPRESSION TAG SEQADV 7L9Y ALA A 1610 UNP Q460N5 EXPRESSION TAG SEQADV 7L9Y SER B 1608 UNP Q460N5 EXPRESSION TAG SEQADV 7L9Y ASN B 1609 UNP Q460N5 EXPRESSION TAG SEQADV 7L9Y ALA B 1610 UNP Q460N5 EXPRESSION TAG SEQADV 7L9Y SER C 1608 UNP Q460N5 EXPRESSION TAG SEQADV 7L9Y ASN C 1609 UNP Q460N5 EXPRESSION TAG SEQADV 7L9Y ALA C 1610 UNP Q460N5 EXPRESSION TAG SEQADV 7L9Y SER D 1608 UNP Q460N5 EXPRESSION TAG SEQADV 7L9Y ASN D 1609 UNP Q460N5 EXPRESSION TAG SEQADV 7L9Y ALA D 1610 UNP Q460N5 EXPRESSION TAG SEQRES 1 A 194 SER ASN ALA ASP MET LYS GLN GLN ASN PHE CYS VAL VAL SEQRES 2 A 194 GLU LEU LEU PRO SER ASP PRO GLU TYR ASN THR VAL ALA SEQRES 3 A 194 SER LYS PHE ASN GLN THR CYS SER HIS PHE ARG ILE GLU SEQRES 4 A 194 LYS ILE GLU ARG ILE GLN ASN PRO ASP LEU TRP ASN SER SEQRES 5 A 194 TYR GLN ALA LYS LYS LYS THR MET ASP ALA LYS ASN GLY SEQRES 6 A 194 GLN THR MET ASN GLU LYS GLN LEU PHE HIS GLY THR ASP SEQRES 7 A 194 ALA GLY SER VAL PRO HIS VAL ASN ARG ASN GLY PHE ASN SEQRES 8 A 194 ARG SER TYR ALA GLY LYS ASN ALA VAL ALA TYR GLY LYS SEQRES 9 A 194 GLY THR TYR PHE ALA VAL ASN ALA ASN TYR SER ALA ASN SEQRES 10 A 194 ASP THR TYR SER ARG PRO ASP ALA ASN GLY ARG LYS HIS SEQRES 11 A 194 VAL TYR TYR VAL ARG VAL LEU THR GLY ILE TYR THR HIS SEQRES 12 A 194 GLY ASN HIS SER LEU ILE VAL PRO PRO SER LYS ASN PRO SEQRES 13 A 194 GLN ASN PRO THR ASP LEU TYR ASP THR VAL THR ASP ASN SEQRES 14 A 194 VAL HIS HIS PRO SER LEU PHE VAL ALA PHE TYR ASP TYR SEQRES 15 A 194 GLN ALA TYR PRO GLU TYR LEU ILE THR PHE ARG LYS SEQRES 1 B 194 SER ASN ALA ASP MET LYS GLN GLN ASN PHE CYS VAL VAL SEQRES 2 B 194 GLU LEU LEU PRO SER ASP PRO GLU TYR ASN THR VAL ALA SEQRES 3 B 194 SER LYS PHE ASN GLN THR CYS SER HIS PHE ARG ILE GLU SEQRES 4 B 194 LYS ILE GLU ARG ILE GLN ASN PRO ASP LEU TRP ASN SER SEQRES 5 B 194 TYR GLN ALA LYS LYS LYS THR MET ASP ALA LYS ASN GLY SEQRES 6 B 194 GLN THR MET ASN GLU LYS GLN LEU PHE HIS GLY THR ASP SEQRES 7 B 194 ALA GLY SER VAL PRO HIS VAL ASN ARG ASN GLY PHE ASN SEQRES 8 B 194 ARG SER TYR ALA GLY LYS ASN ALA VAL ALA TYR GLY LYS SEQRES 9 B 194 GLY THR TYR PHE ALA VAL ASN ALA ASN TYR SER ALA ASN SEQRES 10 B 194 ASP THR TYR SER ARG PRO ASP ALA ASN GLY ARG LYS HIS SEQRES 11 B 194 VAL TYR TYR VAL ARG VAL LEU THR GLY ILE TYR THR HIS SEQRES 12 B 194 GLY ASN HIS SER LEU ILE VAL PRO PRO SER LYS ASN PRO SEQRES 13 B 194 GLN ASN PRO THR ASP LEU TYR ASP THR VAL THR ASP ASN SEQRES 14 B 194 VAL HIS HIS PRO SER LEU PHE VAL ALA PHE TYR ASP TYR SEQRES 15 B 194 GLN ALA TYR PRO GLU TYR LEU ILE THR PHE ARG LYS SEQRES 1 C 194 SER ASN ALA ASP MET LYS GLN GLN ASN PHE CYS VAL VAL SEQRES 2 C 194 GLU LEU LEU PRO SER ASP PRO GLU TYR ASN THR VAL ALA SEQRES 3 C 194 SER LYS PHE ASN GLN THR CYS SER HIS PHE ARG ILE GLU SEQRES 4 C 194 LYS ILE GLU ARG ILE GLN ASN PRO ASP LEU TRP ASN SER SEQRES 5 C 194 TYR GLN ALA LYS LYS LYS THR MET ASP ALA LYS ASN GLY SEQRES 6 C 194 GLN THR MET ASN GLU LYS GLN LEU PHE HIS GLY THR ASP SEQRES 7 C 194 ALA GLY SER VAL PRO HIS VAL ASN ARG ASN GLY PHE ASN SEQRES 8 C 194 ARG SER TYR ALA GLY LYS ASN ALA VAL ALA TYR GLY LYS SEQRES 9 C 194 GLY THR TYR PHE ALA VAL ASN ALA ASN TYR SER ALA ASN SEQRES 10 C 194 ASP THR TYR SER ARG PRO ASP ALA ASN GLY ARG LYS HIS SEQRES 11 C 194 VAL TYR TYR VAL ARG VAL LEU THR GLY ILE TYR THR HIS SEQRES 12 C 194 GLY ASN HIS SER LEU ILE VAL PRO PRO SER LYS ASN PRO SEQRES 13 C 194 GLN ASN PRO THR ASP LEU TYR ASP THR VAL THR ASP ASN SEQRES 14 C 194 VAL HIS HIS PRO SER LEU PHE VAL ALA PHE TYR ASP TYR SEQRES 15 C 194 GLN ALA TYR PRO GLU TYR LEU ILE THR PHE ARG LYS SEQRES 1 D 194 SER ASN ALA ASP MET LYS GLN GLN ASN PHE CYS VAL VAL SEQRES 2 D 194 GLU LEU LEU PRO SER ASP PRO GLU TYR ASN THR VAL ALA SEQRES 3 D 194 SER LYS PHE ASN GLN THR CYS SER HIS PHE ARG ILE GLU SEQRES 4 D 194 LYS ILE GLU ARG ILE GLN ASN PRO ASP LEU TRP ASN SER SEQRES 5 D 194 TYR GLN ALA LYS LYS LYS THR MET ASP ALA LYS ASN GLY SEQRES 6 D 194 GLN THR MET ASN GLU LYS GLN LEU PHE HIS GLY THR ASP SEQRES 7 D 194 ALA GLY SER VAL PRO HIS VAL ASN ARG ASN GLY PHE ASN SEQRES 8 D 194 ARG SER TYR ALA GLY LYS ASN ALA VAL ALA TYR GLY LYS SEQRES 9 D 194 GLY THR TYR PHE ALA VAL ASN ALA ASN TYR SER ALA ASN SEQRES 10 D 194 ASP THR TYR SER ARG PRO ASP ALA ASN GLY ARG LYS HIS SEQRES 11 D 194 VAL TYR TYR VAL ARG VAL LEU THR GLY ILE TYR THR HIS SEQRES 12 D 194 GLY ASN HIS SER LEU ILE VAL PRO PRO SER LYS ASN PRO SEQRES 13 D 194 GLN ASN PRO THR ASP LEU TYR ASP THR VAL THR ASP ASN SEQRES 14 D 194 VAL HIS HIS PRO SER LEU PHE VAL ALA PHE TYR ASP TYR SEQRES 15 D 194 GLN ALA TYR PRO GLU TYR LEU ILE THR PHE ARG LYS HET XRM A1901 26 HET CL A1902 1 HET CL A1903 1 HET EDO A1904 4 HET XRM B1901 26 HET CL B1902 1 HET EDO B1903 4 HET EDO B1904 4 HET XRM C1901 26 HET CL C1902 1 HET XRM D1901 26 HET CL D1902 1 HET EDO D1903 4 HETNAM XRM 7-(CYCLOPENTYLAMINO)-5-FLUORO-2-{[(PIPERIDIN-4-YL) HETNAM 2 XRM SULFANYL]METHYL}QUINAZOLIN-4(3H)-ONE HETNAM CL CHLORIDE ION HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 5 XRM 4(C19 H25 F N4 O S) FORMUL 6 CL 5(CL 1-) FORMUL 8 EDO 4(C2 H6 O2) FORMUL 18 HOH *77(H2 O) HELIX 1 AA1 ASP A 1626 SER A 1641 1 16 HELIX 2 AA2 ASN A 1653 ALA A 1669 1 17 HELIX 3 AA3 ASP A 1685 GLY A 1687 5 3 HELIX 4 AA4 SER A 1688 GLY A 1696 1 9 HELIX 5 AA5 ASN A 1698 GLY A 1703 1 6 HELIX 6 AA6 ASN A 1718 ALA A 1723 1 6 HELIX 7 AA7 TYR A 1787 TYR A 1789 5 3 HELIX 8 AA8 ASP B 1626 SER B 1641 1 16 HELIX 9 AA9 ASN B 1653 ALA B 1669 1 17 HELIX 10 AB1 ASP B 1685 GLY B 1687 5 3 HELIX 11 AB2 SER B 1688 GLY B 1696 1 9 HELIX 12 AB3 ASN B 1698 GLY B 1703 1 6 HELIX 13 AB4 ASN B 1718 ALA B 1723 1 6 HELIX 14 AB5 TYR B 1787 TYR B 1789 5 3 HELIX 15 AB6 ASP C 1626 SER C 1641 1 16 HELIX 16 AB7 ASN C 1653 ALA C 1669 1 17 HELIX 17 AB8 ASP C 1685 GLY C 1687 5 3 HELIX 18 AB9 SER C 1688 GLY C 1696 1 9 HELIX 19 AC1 ASN C 1698 GLY C 1703 1 6 HELIX 20 AC2 ASN C 1718 ALA C 1723 1 6 HELIX 21 AC3 ASP D 1626 SER D 1641 1 16 HELIX 22 AC4 ASN D 1653 ALA D 1669 1 17 HELIX 23 AC5 ASP D 1685 GLY D 1687 5 3 HELIX 24 AC6 SER D 1688 GLY D 1696 1 9 HELIX 25 AC7 ASN D 1698 GLY D 1703 1 6 HELIX 26 AC8 ASN D 1718 ALA D 1723 1 6 SHEET 1 AA110 GLU A1677 THR A1684 0 SHEET 2 AA110 LYS A1736 LEU A1744 -1 O VAL A1741 N LEU A1680 SHEET 3 AA110 ALA A1791 ARG A1800 -1 O PHE A1799 N LYS A1736 SHEET 4 AA110 ARG A1644 GLN A1652 -1 N ARG A1644 O ARG A1800 SHEET 5 AA110 PHE A1617 LEU A1622 -1 N VAL A1620 O ARG A1650 SHEET 6 AA110 PHE D1617 LEU D1622 -1 O PHE D1617 N VAL A1619 SHEET 7 AA110 ARG D1644 GLN D1652 -1 O ARG D1650 N VAL D1620 SHEET 8 AA110 ALA D1791 ARG D1800 -1 O ARG D1800 N ARG D1644 SHEET 9 AA110 LYS D1736 LEU D1744 -1 N LYS D1736 O PHE D1799 SHEET 10 AA110 GLU D1677 THR D1684 -1 N LEU D1680 O VAL D1741 SHEET 1 AA2 4 THR A1713 ALA A1716 0 SHEET 2 AA2 4 LEU A1782 ALA A1785 -1 O ALA A1785 N THR A1713 SHEET 3 AA2 4 THR A1772 THR A1774 -1 N VAL A1773 O VAL A1784 SHEET 4 AA2 4 TYR A1748 HIS A1750 1 N THR A1749 O THR A1774 SHEET 1 AA3 2 SER A1760 ASN A1762 0 SHEET 2 AA3 2 ASN A1765 LEU A1769 -1 O ASP A1768 N LYS A1761 SHEET 1 AA410 GLU B1677 THR B1684 0 SHEET 2 AA410 LYS B1736 LEU B1744 -1 O VAL B1741 N LEU B1680 SHEET 3 AA410 ALA B1791 ARG B1800 -1 O PHE B1799 N LYS B1736 SHEET 4 AA410 ARG B1644 GLN B1652 -1 N ARG B1644 O ARG B1800 SHEET 5 AA410 PHE B1617 LEU B1622 -1 N VAL B1620 O ARG B1650 SHEET 6 AA410 PHE C1617 LEU C1622 -1 O VAL C1619 N PHE B1617 SHEET 7 AA410 ARG C1644 GLN C1652 -1 O ARG C1650 N VAL C1620 SHEET 8 AA410 ALA C1791 ARG C1800 -1 O ARG C1800 N ARG C1644 SHEET 9 AA410 LYS C1736 LEU C1744 -1 N LYS C1736 O PHE C1799 SHEET 10 AA410 GLU C1677 THR C1684 -1 N LEU C1680 O VAL C1741 SHEET 1 AA5 4 THR B1713 ALA B1716 0 SHEET 2 AA5 4 LEU B1782 ALA B1785 -1 O ALA B1785 N THR B1713 SHEET 3 AA5 4 THR B1772 THR B1774 -1 N VAL B1773 O VAL B1784 SHEET 4 AA5 4 TYR B1748 HIS B1750 1 N THR B1749 O THR B1774 SHEET 1 AA6 4 THR C1713 ALA C1716 0 SHEET 2 AA6 4 LEU C1782 ALA C1785 -1 O ALA C1785 N THR C1713 SHEET 3 AA6 4 THR C1772 THR C1774 -1 N VAL C1773 O VAL C1784 SHEET 4 AA6 4 TYR C1748 HIS C1750 1 N THR C1749 O THR C1774 SHEET 1 AA7 2 SER C1760 ASN C1762 0 SHEET 2 AA7 2 ASN C1765 LEU C1769 -1 O ASP C1768 N LYS C1761 SHEET 1 AA8 4 THR D1713 ALA D1716 0 SHEET 2 AA8 4 LEU D1782 ALA D1785 -1 O ALA D1785 N THR D1713 SHEET 3 AA8 4 THR D1772 THR D1774 -1 N VAL D1773 O VAL D1784 SHEET 4 AA8 4 TYR D1748 HIS D1750 1 N THR D1749 O THR D1774 SHEET 1 AA9 2 SER D1760 ASN D1762 0 SHEET 2 AA9 2 ASN D1765 LEU D1769 -1 O ASP D1768 N LYS D1761 SSBOND 1 CYS A 1618 CYS D 1618 1555 1555 2.12 SSBOND 2 CYS B 1618 CYS C 1618 1555 1555 2.10 CRYST1 72.650 92.230 144.540 90.00 90.00 90.00 P 21 21 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013765 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010842 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006919 0.00000